Edition:
United Kingdom

Cymabay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Global Select Market

12.94USD
9:00pm BST
Change (% chg)

$0.22 (+1.73%)
Prev Close
$12.72
Open
$12.70
Day's High
$13.01
Day's Low
$12.65
Volume
86,463
Avg. Vol
237,104
52-wk High
$15.00
52-wk Low
$6.33

About

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)

Overall

Beta: 1.77
Market Cap(Mil.): $858.05
Shares Outstanding(Mil.): 67.46
Dividend: --
Yield (%): --

Financials

  CBAY.OQ Industry Sector
P/E (TTM): -- 109.42 62.41
EPS (TTM): -1.26 -- --
ROI: -55.75 7.98 11.81
ROE: -56.82 8.13 12.64

Earnings vs. Estimates